Onyx Therapeutics

Organisation

Trials

NCT03029234
Collaborator, Phase 3, Completed, 126 people, 24 Jan 2017
NCT02405364
Collaborator, Phase 2, Completed, 46 people, 1 Apr 2015
NCT01969565
Collaborator, Phase 2, Terminated, 1 person, 25 Oct 2013
NCT01813227
Collaborator, Phase 2, Completed, 7 people, 18 Mar 2013
NCT01714609
Collaborator, Phase 2, Completed, 10 people, 26 Oct 2012
NCT01585870
Collaborator, Phase 1, Completed, 40 people, 26 Apr 2012
NCT01559935
Collaborator, Phase 2, Completed, 74 people, 21 Mar 2012
NCT01549431
Collaborator, Phase 1, Completed, 32 people, 9 Mar 2012
NCT01402284
Collaborator, Phase 2, Completed, 45 people, 26 Jul 2011
NCT01254890
Collaborator, Phase 1/2, Completed, 60 people, 7 Dec 2010
Phase III Trial Comparing Capecitabine in Combination With Sorafenib or Placebo in the Treatment of Locally Advanced or Metastatic HER2-Negative Breast Cancer
Collaborator, Phase 3, Completed, 537 people, 4 Nov 2010
NCT01029054
Collaborator, Phase 1/2, Completed, 53 people, 9 Dec 2009
NCT00813293
Collaborator, Phase 2, Completed, 20 people, 23 Dec 2008